Indicators

Latest News about ARVN

Recent news which mentions ARVN

< Previous 1 2 3 4 Next >

Where Arvinas Stands With Analysts

May 05, 2025

Apple To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Friday

May 02, 2025

Apple To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Friday

May 02, 2025

Dow, Nasdaq Up Over 400 Points As Tech Rallies

May 01, 2025

Dow Surges Over 300 Points; McDonald's Posts Weak Revenue

May 01, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session

May 01, 2025

Nasdaq Jumps 1.5%; Microsoft Posts Upbeat Results

May 01, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session

May 01, 2025

Earnings Scheduled For May 1, 2025

May 01, 2025

A Peek at Arvinas's Future Earnings

April 30, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

April 30, 2025

Arvinas Potential Parkinson's Treatment Shows Positive Data In Human Study

April 04, 2025

Top 3 Health Care Stocks That Are Set To Fly This Month

March 26, 2025

Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday

March 12, 2025

This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

March 12, 2025

Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In Trial

March 11, 2025

Crude Oil Gains 1%; Ciena Earnings Top Views

March 11, 2025

US Stocks Mixed; Kohl's Shares Plunge After Q4 Results

March 11, 2025

These Analysts Revise Their Forecasts On Arvinas After Q4 Results

February 12, 2025

Snowflake To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Wednesday

February 12, 2025

US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?

February 11, 2025

Earnings Scheduled For February 11, 2025

February 11, 2025

What 4 Analyst Ratings Have To Say About Arvinas

February 07, 2025

2 Growth Stocks That Could Rocket Higher in the First Quarter of 2025

January 21, 2025

Demystifying Arvinas: Insights From 5 Analyst Reviews

December 11, 2024

Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Clinical Benefit In Breast Cancer Patients

December 10, 2024

Unveiling 4 Analyst Insights On Arvinas

November 20, 2024

What's Next: Arvinas's Earnings Preview

October 29, 2024

Critical Insights From Arvinas Analyst Ratings: What You Need To Know

September 09, 2024

The Latest Analyst Ratings For Arvinas

July 31, 2024

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.